Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Pratheek Kakkasseril

Vascular Surgery Youngstown, OH Medical Doctor

NPI 1609195643 CMS profile 408770

1001 Belmont Ave, Ste D, Youngstown, OH 44504

Open in the dashboard

General payments

$22,616

249 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pratheek Kakkasseril of Youngstown, OH is reported in the CMS Open Payments database as having received $22,616 across 249 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,731 55
2024 General $2,599 29
2023 General $1,001 38
2022 General $8,990 26
2021 General $1,543 36
2020 General $61 4
2019 General $5,692 61

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pratheek Kakkasseril
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Pratheek Kakkasseril were reported at $2,731. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Pratheek Kakkasseril Vascular Surgery median Middle half National median
2019 $5,692 $796 $226–$2,363 $163
2020 $61 $348 $118–$1,110 $114
2021 $1,543 $471 $158–$1,421 $132
2022 $8,990 $725 $222–$2,183 $149
2023 $1,001 $836 $257–$2,440 $160
2024 $2,599 $909 $252–$2,619 $164
2025 $2,731 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $14,112 128 payments
  2. Bard Peripheral Vascular, Inc. $4,575 9 payments
  3. Silk Road Medical, Inc. $1,151 12 payments
  4. Organogenesis Inc. $531 19 payments
  5. Integra LifeSciences Corporation $332 5 payments
  6. Medtronic Vascular, Inc. $290 15 payments
  7. Abbott Laboratories $193 3 payments
  8. Pfizer Inc. $143 12 payments
  9. Cook Medical LLC $134 4 payments
  10. Davol Inc. $132 1 payment
  11. Other $1,024 41 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $10,530 17 payments
  2. Food and Beverage $6,381 229 payments
  3. Consulting Fee $3,850 1 payment
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,600 1 payment
  5. Long term medical supply or device loan $255 1 payment
Products named General payments · program years 2019–2025
  1. IN.PACT Admiral Drug-Coated Balloons $9,002 31 payments
  2. HawkOne $2,617 41 payments
  3. ENDURANT IIS $1,833 22 payments
  4. ENROUTE Transcarotid Stent $1,151 12 payments
  5. ENROUTE Transcarotid Neuroprotection System $1,151 12 payments
  6. ENHANCE Transcarotid Peripheral Access Kit $1,055 9 payments
  7. ENROUTE .014 Guidewire $1,055 9 payments
  8. Heli-FX EndoAnchor System $331 8 payments
  9. IN.PACT Admiral Drug-Coated Balloons $271 9 payments
  10. ACell $255 1 payment
  11. Other $3,525 150 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

490

Median for Vascular Surgery: 122

Drug cost

$32,440

Median for Vascular Surgery: $14,135

Branded share of claims

49.8%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 24 $25,271
Cilostazol Generic 177 $3,271
Clopidogrel Clopidogrel Bisulfate Brand 129 $1,462
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 78 $1,184
Gabapentin Generic 21 $474
Morphine Sulfate Er Morphine Sulfate Brand 13 $401
Oxycodone Hcl Generic 33 $208
Doxycycline Hyclate Generic 15 $169

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 99 billing codes

Paid by Medicare

$113,498

Medicare's payments for the services billed

Medicare patients

297

Average age 74

Services billed

1,390

124 women, 173 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Diabetes 58%
Chronic kidney disease 52%
Ischemic heart disease 44%
Heart failure 40%
COPD 34%
Atrial fibrillation 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

249 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record